Millennium Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Sell
17,349
-81,799
-83% -$14M ﹤0.01% 3492
2025
Q4
$16.7M Buy
99,148
+32,540
+49% +$5.29M 0.01% 1739
2025
Q3
$9.62M Sell
66,608
-41,792
-39% -$5.7M ﹤0.01% 2428
2025
Q2
$13.7M Buy
108,400
+66,724
+160% +$8.19M 0.01% 1941
2025
Q1
$5.33M Sell
41,676
-150,107
-78% -$20.4M ﹤0.01% 2799
2024
Q4
$25.4M Buy
191,783
+93,552
+95% +$13.2M 0.01% 1330
2024
Q3
$14.3M Buy
98,231
+32,928
+50% +$4.76M 0.01% 1863
2024
Q2
$8.96M Sell
65,303
-288,930
-82% -$38.6M ﹤0.01% 2185
2024
Q1
$48.6M Buy
354,233
+189,775
+115% +$25.9M 0.02% 843
2023
Q4
$22.3M Sell
164,458
-109,947
-40% -$13.4M 0.01% 1460
2023
Q3
$33.6M Sell
274,405
-106,575
-28% -$13.6M 0.02% 999
2023
Q2
$48.4M Buy
380,980
+368,681
+2,998% +$47.9M 0.02% 760
2023
Q1
$1.59M Sell
12,299
-284,636
-96% -$37.3M ﹤0.01% 3653
2022
Q4
$39M Buy
296,935
+93,171
+46% +$12M 0.02% 916
2022
Q3
$23.8M Buy
203,764
+15,120
+8% +$1.88M 0.01% 1183
2022
Q2
$22.2M Buy
188,644
+54,629
+41% +$6.48M 0.01% 1207
2022
Q1
$17.5M Buy
134,015
+111,334
+491% +$14.5M 0.01% 1536
2021
Q4
$3.46M Sell
22,681
-111,424
-83% -$17.3M ﹤0.01% 3249
2021
Q3
$21.7M Sell
134,105
-391,394
-74% -$65.9M 0.01% 1247
2021
Q2
$86M Buy
525,499
+271,368
+107% +$41.8M 0.05% 371
2021
Q1
$38.3M Buy
254,131
+225,261
+780% +$35.8M 0.03% 645
2020
Q4
$4.37M Buy
+28,870
New +$4.13M ﹤0.01% 2570
2020
Q3
Sell
-22,304
Closed -$3.03M 4616
2020
Q2
$3.05M Sell
22,304
-233,225
-91% -$29.7M ﹤0.01% 2203
2020
Q1
$27.5M Sell
255,529
-28,574
-10% -$3.29M 0.06% 325
2019
Q4
$34.2M Sell
284,103
-106,963
-27% -$11.9M 0.04% 540
2019
Q3
$38.9M Buy
391,066
+84,841
+28% +$8.88M 0.06% 407
2019
Q2
$33.4M Buy
306,225
+290,537
+1,852% +$30.9M 0.05% 508
2019
Q1
$1.75M Sell
15,688
-470,972
-97% -$51.7M ﹤0.01% 2500
2018
Q4
$46.9M Buy
486,660
+425,453
+695% +$45.2M 0.07% 363
2018
Q3
$7.46M Sell
61,207
-51,055
-45% -$6.01M 0.01% 1516
2018
Q2
$12.3M Buy
112,262
+104,219
+1,296% +$11.1M 0.02% 1178
2018
Q1
$859K Sell
8,043
-2,516
-24% -$279K ﹤0.01% 2772
2017
Q4
$1.13M Buy
+10,559
New +$1.13M ﹤0.01% 2631
2017
Q3
Sell
-78,843
Closed -$8.15M 3664
2017
Q2
$8.15M Buy
+78,843
New +$7.77M 0.01% 1181
2017
Q1
Sell
-8,625
Closed -$763K 3643
2016
Q4
$763K Sell
8,625
-39,102
-82% -$3.56M ﹤0.01% 2406
2016
Q3
$4.61M Buy
+47,727
New +$4.54M 0.01% 1385
2016
Q2
Sell
-101,529
Closed -$8.83M 3339
2016
Q1
$8.83M Sell
101,529
-433,947
-81% -$38.8M 0.02% 909
2015
Q4
$60.4M Sell
535,476
-279,009
-34% -$30.3M 0.13% 178
2015
Q3
$82.4M Buy
814,485
+370,863
+84% +$44.5M 0.16% 126
2015
Q2
$54.6M Buy
+443,622
New +$53.1M 0.1% 239
2015
Q1
Sell
-187,974
Closed -$20.7M 3811
2014
Q4
$19M Sell
187,974
-234,966
-56% -$22.8M 0.04% 629
2014
Q3
$38.6M Buy
422,940
+226,497
+115% +$19.9M 0.1% 234
2014
Q2
$16.8M Buy
196,443
+183,741
+1,447% +$14.5M 0.05% 556
2014
Q1
$1M Buy
12,702
+3,813
+43% +$318K ﹤0.01% 2224
2013
Q4
$673K Buy
+8,889
New +$631K ﹤0.01% 2531

Other funds holding IBB

Millennium Management's IBB Position: Q1 2026 in Review

Millennium Management reduced its iShares Biotechnology ETF (IBB) stake by 83% in Q1 2026, selling an estimated $14M and leaving 17,349 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3492.

Millennium Management first reported a position in IBB in Q4 2013 and has held it in 45 quarters since. The position peaked at $86M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Millennium Management held 17,349 shares of iShares Biotechnology ETF worth $2.93M as of Q1 2026.
  • Millennium Management sold 81,799 iShares Biotechnology ETF shares in Q1 2026, an estimated $14M.
  • iShares Biotechnology ETF made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3492 holding.
  • Millennium Management first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 45 quarters since.
  • Millennium Management's iShares Biotechnology ETF position peaked at $86M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.